Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries

Priming after a Fractional Dose of Inactivated Poliovirus Vaccine

(2013) Sonia Resik et al.   NEW ENGLAND JOURNAL OF MEDICINE

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

(2012) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

(2012) Sarah L. Sheridan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzaetype b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers

(2012) Beatriz Quiambao et al.   Human Vaccines & Immunotherapeutics

Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants

(2011) Pope Kosalaraksa et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle‐Free Device in Cuba

(2010) Sonia Resik et al.   JOURNAL OF INFECTIOUS DISEASES

Fractional Doses of Inactivated Poliovirus Vaccine in Oman

(2010) Ali Jafer Mohammed et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving the cellular pertussis vaccine: Increased potency and consistency

(2007) Marcel Thalen et al.   VACCINE